Currently, Memorial Sloan Kettering offers the only clinical trial worldwide for people with an advanced but potentially operable thymoma. The trial is part of the effort by our Thymoma Working Group to establish diagnosis and treatment standards for these cancers as well as for thymic tumors and thymic carcinoids. Many of the clinicians in this group are world leaders in the field.
